Maureen Trudeau
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies 107
- Oncology top 0.1%
- HER2/EGFR in Cancer Research 53
- Cancer Treatment and Pharmacology 47
- Global Cancer Incidence and Screening 21
- Pathology and Forensic Medicine top 0.5%
-
- Advanced Breast Cancer Therapies 18
-
- Economic and Financial Impacts of Cancer 34
- Health Systems, Economic Evaluations, Quality of Life 33
-
- Estrogen and related hormone effects 21
- Co-authors
- Kathleen I. PritchardWedad HannaSteven A. NarodRebecca DentPing SunEllen RawlinsonCarol SawkaL. Lickley
- Journals
- Journal of Clinical Oncology (63 papers)Breast Cancer Research and Treatment (20 papers)Cancer Research (13 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Maureen Trudeau
249 papers receiving 12.5k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Cancer Research 5.0k
- Oncology 7.4k
- Pathology and Forensic Medicine 1.4k
- Pulmonary and Respiratory Medicine 2.2k
- Radiology, Nuclear Medicine and Imaging 1.5k
Countries citing papers authored by Maureen Trudeau
This map shows the geographic impact of Maureen Trudeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Trudeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Trudeau more than expected).
Fields of papers citing papers by Maureen Trudeau
This network shows the impact of papers produced by Maureen Trudeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Trudeau. The network helps show where Maureen Trudeau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maureen Trudeau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 18 | |
| 6 | 2023 | 1 | |
| 7 | 2020 | 76 | |
| 8 | 2019 | 8 | |
| 9 | 2019 | 1 | |
| 10 | 2018 | 7 | |
| 11 | 2017 | 10 | |
| 12 | 2017 | 42 | |
| 13 | 2016 | 30 | |
| 14 | 2014 | 6 | |
| 15 | Closing the personalized medicine information gap: HER2 test documentation practice. | 2013 | 8 |
| 16 | 2012 | 50 | |
| 17 | 2011 | 20 | |
| 18 | 2008 | 152 | |
| 19 | Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrencebreakdown → | 2007 | 3772 |
| 20 | Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Studybreakdown → | 2002 | 518 |
About Maureen Trudeau
Maureen Trudeau is a scholar working on Cancer Research, Oncology and Economics and Econometrics, having authored 259 papers that have together received 12.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (107 papers), HER2/EGFR in Cancer Research (53 papers), Cancer Treatment and Pharmacology (47 papers), Economic and Financial Impacts of Cancer (34 papers), Health Systems, Economic Evaluations, Quality of Life (33 papers), Global Cancer Incidence and Screening (21 papers), Estrogen and related hormone effects (21 papers) and Advanced Breast Cancer Therapies (18 papers). The work is most often cited by research in Cancer Research (5.0k citations), Oncology (7.4k citations) and Pathology and Forensic Medicine (1.4k citations). Maureen Trudeau has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Kathleen I. Pritchard, Wedad Hanna, Steven A. Narod, Rebecca Dent, Ping Sun, Ellen Rawlinson, Carol Sawka, L. Lickley, Pamela J. Goodwin and Nicky Hood. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, Oncotarget and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.